These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 12574517)

  • 21. Evasion of human innate and acquired immunity by a bacterial homolog of CD11b that inhibits opsonophagocytosis.
    Lei B; DeLeo FR; Hoe NP; Graham MR; Mackie SM; Cole RL; Liu M; Hill HR; Low DE; Federle MJ; Scott JR; Musser JM
    Nat Med; 2001 Dec; 7(12):1298-305. PubMed ID: 11726969
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endopeptidase PepO Regulates the SpeB Cysteine Protease and Is Essential for the Virulence of Invasive M1T1 Streptococcus pyogenes.
    Brouwer S; Cork AJ; Ong CY; Barnett TC; West NP; McIver KS; Walker MJ
    J Bacteriol; 2018 Apr; 200(8):. PubMed ID: 29378883
    [No Abstract]   [Full Text] [Related]  

  • 23. Down-regulation of proinflammatory capacity during apoptosis in human polymorphonuclear leukocytes.
    Kobayashi SD; Voyich JM; Braughton KR; DeLeo FR
    J Immunol; 2003 Mar; 170(6):3357-68. PubMed ID: 12626596
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inactivation of the group A Streptococcus regulator srv results in chromosome wide reduction of transcript levels, and changes in extracellular levels of Sic and SpeB.
    Reid SD; Chaussee MS; Doern CD; Chaussee MA; Montgomery AG; Sturdevant DE; Musser JM
    FEMS Immunol Med Microbiol; 2006 Nov; 48(2):283-92. PubMed ID: 16999824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Virulence factor regulation and regulatory networks in Streptococcus pyogenes and their impact on pathogen-host interactions.
    Kreikemeyer B; McIver KS; Podbielski A
    Trends Microbiol; 2003 May; 11(5):224-32. PubMed ID: 12781526
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Induction of group A Streptococcus virulence by a human antimicrobial peptide.
    Gryllos I; Tran-Winkler HJ; Cheng MF; Chung H; Bolcome R; Lu W; Lehrer RI; Wessels MR
    Proc Natl Acad Sci U S A; 2008 Oct; 105(43):16755-60. PubMed ID: 18936485
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The VraSR regulatory system contributes to virulence in Streptococcus suis via resistance to innate immune defenses.
    Chang P; Li W; Shi G; Li H; Yang X; Xia Z; Ren Y; Li Z; Chen H; Bei W
    Virulence; 2018 Dec; 9(1):771-782. PubMed ID: 29471718
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Defects in ex vivo and in vivo growth and sensitivity to osmotic stress of group A Streptococcus caused by interruption of response regulator gene vicR.
    Liu M; Hanks TS; Zhang J; McClure MJ; Siemsen DW; Elser JL; Quinn MT; Lei B
    Microbiology (Reading); 2006 Apr; 152(Pt 4):967-978. PubMed ID: 16549661
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of Group A Streptococcus Genes Directly Regulated by CsrRS and Novel Intermediate Regulators.
    Finn MB; Ramsey KM; Dove SL; Wessels MR
    mBio; 2021 Aug; 12(4):e0164221. PubMed ID: 34253064
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RocA Has Serotype-Specific Gene Regulatory and Pathogenesis Activities in Serotype M28 Group A Streptococcus.
    Bernard PE; Kachroo P; Zhu L; Beres SB; Eraso JM; Kajani Z; Long SW; Musser JM; Olsen RJ
    Infect Immun; 2018 Nov; 86(11):. PubMed ID: 30126898
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cytotoxic effects of streptolysin o and streptolysin s enhance the virulence of poorly encapsulated group a streptococci.
    Sierig G; Cywes C; Wessels MR; Ashbaugh CD
    Infect Immun; 2003 Jan; 71(1):446-55. PubMed ID: 12496195
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Virulence Role of the GlcNAc Side Chain of the Lancefield Cell Wall Carbohydrate Antigen in Non-M1-Serotype Group A
    Henningham A; Davies MR; Uchiyama S; van Sorge NM; Lund S; Chen KT; Walker MJ; Cole JN; Nizet V
    mBio; 2018 Jan; 9(1):. PubMed ID: 29382733
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression profile.
    Hertzén E; Johansson L; Kansal R; Hecht A; Dahesh S; Janos M; Nizet V; Kotb M; Norrby-Teglund A
    PLoS One; 2012; 7(4):e35218. PubMed ID: 22511985
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular pathogenesis of necrotizing fasciitis.
    Olsen RJ; Musser JM
    Annu Rev Pathol; 2010; 5():1-31. PubMed ID: 19737105
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibitory effects of fibrinogen on phagocytic killing of streptococcal isolates from humans, cattle and horses.
    Traore MY; Valentin-Weigand P; Chhatwal GS; Blobel H
    Vet Microbiol; 1991 Aug; 28(3):295-302. PubMed ID: 1897132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences.
    Nasser W; Beres SB; Olsen RJ; Dean MA; Rice KA; Long SW; Kristinsson KG; Gottfredsson M; Vuopio J; Raisanen K; Caugant DA; Steinbakk M; Low DE; McGeer A; Darenberg J; Henriques-Normark B; Van Beneden CA; Hoffmann S; Musser JM
    Proc Natl Acad Sci U S A; 2014 Apr; 111(17):E1768-76. PubMed ID: 24733896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. D-alanylation of teichoic acids promotes group a streptococcus antimicrobial peptide resistance, neutrophil survival, and epithelial cell invasion.
    Kristian SA; Datta V; Weidenmaier C; Kansal R; Fedtke I; Peschel A; Gallo RL; Nizet V
    J Bacteriol; 2005 Oct; 187(19):6719-25. PubMed ID: 16166534
    [TBL] [Abstract][Full Text] [Related]  

  • 38. PerR confers phagocytic killing resistance and allows pharyngeal colonization by group A Streptococcus.
    Gryllos I; Grifantini R; Colaprico A; Cary ME; Hakansson A; Carey DW; Suarez-Chavez M; Kalish LA; Mitchell PD; White GL; Wessels MR
    PLoS Pathog; 2008 Sep; 4(9):e1000145. PubMed ID: 18773116
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Streptococcus pyogenes serotype M49 Nra-Ralp3 transcriptional regulatory network and its control of virulence factor expression from the novel eno ralp3 epf sagA pathogenicity region.
    Kreikemeyer B; Nakata M; Köller T; Hildisch H; Kourakos V; Standar K; Kawabata S; Glocker MO; Podbielski A
    Infect Immun; 2007 Dec; 75(12):5698-710. PubMed ID: 17893125
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A chemokine-degrading extracellular protease made by group A Streptococcus alters pathogenesis by enhancing evasion of the innate immune response.
    Sumby P; Zhang S; Whitney AR; Falugi F; Grandi G; Graviss EA; Deleo FR; Musser JM
    Infect Immun; 2008 Mar; 76(3):978-85. PubMed ID: 18174342
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.